AzTrials
AzTrials

Primary DysmenorrheaNCT06075654

Primary Dysmenorrhea Severity in Athletic vs. Non-Athletic Females

An observational study of Primary Dysmenorrhea, run by Cairo University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The aim of the study is to investigate the difference in the severity of primary dysmenorrhea between athletic and non-athletic females. Read more about this study

Who is it for?
Ages 18 to 28 years, women onlyHealthy volunteers can take part
Conditions the study is for
Primary Dysmenorrhea
How many people
628 participants
Where
1 siteEgypt
Study dates
1 Mar 2023to 3 Oct 2023
Phase
Observational
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 to 28 years
  • Women only
  • Healthy volunteers accepted
  • Adult

Study population: The athletic group will be selected from different clubs in Egypt for example; Benha, Tanta, Maadi, and Wadi-Degla clubs. Non- athletic will be selected from females and their their accompanying individuals

Who may be able to join

  • Common inclusion criteria for athletic and non-athletic female.
  • They had a regular menstrual cycle with a menstrual cycle length of 21-30 days.
  • All females were virgins.
  • Their ages ranged from 18 to 28 years old.
  • Their BMI was ranged from 18.5 -29,9 kg/m2
  • They did not use any pharmacological therapies for controlling pain during menstruation and during the application of the study.
Show all 9Show fewer
  • They participated in the exercise for the last ≥ 6 months.
  • They did exercises for ≥ 3 days/ week.
  • They practiced (swimming, basketball, volleyball, ballet, gymnastics, judo, wrestling, karate, and boxing).

Who cannot join

  • History of pelvic pathology or any gynecological disease.
  • They had a history of chronic illness (eg: diabetes).
  • Their symptoms of dysmenorrhea became worse over time

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Khloud Ramadan Abd El- Fatah

    Cairo

Other trials in Egypt

About this study

Official title: "Comparison of the Severity of Primary Dysmenorrhea Between Athletic and Non-Athletic Females: A Cross-Sectional Study" Comparison of the Severity of Primary Dysmenorrhea Between Athletic and Non-Athletic Females: A Cross-Sectional Study.

The aim of the study is to investigate the difference in the severity of primary dysmenorrhea between athletic and non-athletic females.

Read the detailed description

Primary dysmenorrhea is defined as colic pain in the lower abdomen which starts with the onset of menstruation. It is one of the most common gynecological disorders, an important cause of morbidity, and the most common cause of pelvic pain in menstruating girls and women it affects women in any age group. The prevalence varies widely, ranging from 17% to as high as 91%. Between 16% to 29% of women with dysmenorrhea have significant impairment in quality of life and the women's well-being. The rate of absenteeism from school, work, or other activities represents up to 15% of women with dysmenorrhea, dysmenorrhea is considered a source of considerable economic losses due to the costs of medications, medical care, and decreased productivity. Yoga, pilates, stretching, and other types of exercises have a noticeable effect on decreasing pain, and improving general health, and quality of sleep with different health conditions including primary dysmenorrhea. In addition, exercise and physical activity are used widely and proven to not only decrease pain but also improve quality of life, decrease stress, improve mental health, and in management of depression and stress.

For dysmenorrhea the mechanism that explained the effect of exercises on primary dysmenorrhea has been classified according to the intensity of the exercises; moderate -high-intensity exercise was believed to increase the anti-inflammatory cytokines, decrease the overall amount of prostaglandins released because of the decrease of the overall amount of menstrual flow. Low-intensity exercise reduces cortisol levels and prostaglandin synthesis

Being tested
no intervention it is considered (Epidemiological Study)

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • no intervention it is considered (Epidemiological Study)Other

    It was a survey used Visual Analog Scale and WaLIDD scale to measure the severity of primary dysmenorrhea between both groups

Study groups in NCT06075654
Study groupRoleWhat they receive
Athletic Groupathletic females complaining of primary dysmenorrhea, they participated in the exercise for the last ≥ 6 months, did exercises for ≥ 3 days/ week, and practiced (swimming, basketball, volleyball, gymnastics, judo, wrestling, karate, and boxing.
Receives: Other: no intervention it is considered (Epidemiological Study)
Non-Athletic GroupNon-athletic females complaining form primary dysmenorrhea who are have not participated in any physical activity before
Receives: Other: no intervention it is considered (Epidemiological Study)

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Visual Analogue Scale

    The scale that will be used the VAS ;each subject will instructed to put point on line from no pain to tolerable pain

    Measured: Data will be collected at a single time point, which is the baseline assessment

Secondary outcomes (1)
  1. Working ability, location, Intensity, Disability Dysmenorrhea scale.

    measuring a combination of manifestations: subjective (intensity /Wong-Baker, work ability) and objective (days of pain, location).

    In which each aspect of scale are rated from 0 to 3. 0 indicate no dysmenorrhea, 1-4 mild dysmenorrhea, 5-7 moderate dysmenorrhea, 8-12 sever dysmenorrhea.

    Measured: Data will be collected at a single time point, which is the baseline assessment

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted10 Oct 2023
  2. Study start1 Mar 2023
  3. Primary completion21 Sep 2023
  4. Study completion3 Oct 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Observational
Observational model
Other
Time perspective
Cross-sectional
Enrolment
628 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06075654
Sponsor's protocol ID
P.T.REC/012/004091
Status last verified
Oct 2023
First submitted
4 Oct 2023
Last updated
16 Oct 2023
Results posted
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

An observational study of Primary Dysmenorrhea, run by Cairo University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 9 inclusion and 3 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 16 Oct 2023. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Visual Analogue Scale (time frame: Data will be collected at a single time point, which is the baseline assessment). It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 16 Oct 2023.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in